QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)
QQQ   416.28 (-1.68%)
AAPL   165.59 (-0.87%)
MSFT   400.44 (-0.95%)
META   482.20 (-3.91%)
GOOGL   154.01 (-1.28%)
AMZN   174.84 (-2.44%)
TSLA   148.37 (-1.04%)
NVDA   786.21 (-7.15%)
AMD   147.95 (-4.60%)
NIO   3.82 (-4.50%)
BABA   68.93 (+0.07%)
T   16.44 (+0.67%)
F   12.11 (+0.41%)
MU   107.04 (-4.37%)
GE   148.62 (-2.82%)
CGC   8.00 (+2.17%)
DIS   112.29 (-0.12%)
AMC   3.21 (+9.93%)
PFE   25.85 (+1.81%)
PYPL   62.10 (+0.00%)
XOM   119.76 (+1.05%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioqual, Inc. stock logo
BIOQ
Bioqual
$75.00
$75.56
$59.00
$82.00
N/A-0.3233 shsN/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
$0.87
-7.4%
$0.92
$0.40
$10.90
$2.73M2.759,586 shs29,156 shs
iSpecimen Inc. stock logo
ISPC
iSpecimen
$0.31
-25.2%
$0.35
$0.20
$2.05
$2.95M1.69665,047 shs2.32 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioqual, Inc. stock logo
BIOQ
Bioqual
0.00%0.00%-6.25%-3.85%-8.54%
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
-2.34%-4.08%-2.08%-13.56%-87.26%
iSpecimen Inc. stock logo
ISPC
iSpecimen
+97.65%+85.46%+31.56%-11.50%-75.09%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioqual, Inc. stock logo
BIOQ
Bioqual
N/AN/AN/AN/AN/AN/AN/AN/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
0.4636 of 5 stars
2.00.00.00.01.91.70.6
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioqual, Inc. stock logo
BIOQ
Bioqual
N/AN/AN/AN/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
N/AN/A$55.006,221.84% Upside
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioqual, Inc. stock logo
BIOQ
Bioqual
$62.66MN/A$15.00 per share5.00$42.04 per shareN/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
N/AN/AN/AN/A($4.92) per shareN/A
iSpecimen Inc. stock logo
ISPC
iSpecimen
$9.93M0.30N/AN/A$1.07 per share0.29

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioqual, Inc. stock logo
BIOQ
Bioqual
$840K-$0.51N/AN/A-0.76%-1.22%-0.77%4/19/2024 (Estimated)
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
-$36.06M-$9.07N/AN/AN/AN/AN/A-203.00%N/A
iSpecimen Inc. stock logo
ISPC
iSpecimen
-$11.10M-$1.23N/AN/A-111.81%-80.37%-61.99%5/2/2024 (Estimated)

Latest ISPC, ELOX, and BIOQ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2024Q4 2023
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/A-$0.34-$0.34-$0.34N/A$2.58 million
1/23/2024Q2 2024
Bioqual, Inc. stock logo
BIOQ
Bioqual
N/A$0.54+$0.54$0.54N/A$15.87 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioqual, Inc. stock logo
BIOQ
Bioqual
$0.500.67%N/AN/A N/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
N/AN/AN/AN/AN/A
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioqual, Inc. stock logo
BIOQ
Bioqual
N/A
4.20
4.20
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
N/A
0.24
0.24
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/A
1.36
1.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bioqual, Inc. stock logo
BIOQ
Bioqual
N/A
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
2.90%
iSpecimen Inc. stock logo
ISPC
iSpecimen
13.62%

Insider Ownership

CompanyInsider Ownership
Bioqual, Inc. stock logo
BIOQ
Bioqual
39.24%
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
20.20%
iSpecimen Inc. stock logo
ISPC
iSpecimen
32.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bioqual, Inc. stock logo
BIOQ
Bioqual
114N/AN/ANot Optionable
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
183.14 million2.51 millionNot Optionable
iSpecimen Inc. stock logo
ISPC
iSpecimen
539.37 million6.31 millionNot Optionable

ISPC, ELOX, and BIOQ Headlines

SourceHeadline
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.06%U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.06%
msn.com - April 18 at 8:48 PM
iSpecimen Inc. (ISPC) Q4 2023 Earnings Call TranscriptiSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 16 at 7:41 PM
Earnings call: iSpecimen reports full-year 2023 results, aims for 2024 profitabilityEarnings call: iSpecimen reports full-year 2023 results, aims for 2024 profitability
investing.com - March 16 at 7:41 PM
Nvidia GTC AI conference: What to watchNvidia GTC AI conference: What to watch
sg.finance.yahoo.com - March 15 at 12:44 PM
iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call TranscriptiSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 15 at 12:44 PM
iSpecimen Full Year 2023 Earnings: Misses ExpectationsiSpecimen Full Year 2023 Earnings: Misses Expectations
finance.yahoo.com - March 15 at 7:43 AM
iSpecimen Inc: iSpecimen Reports Full Year 2023 ResultsiSpecimen Inc: iSpecimen Reports Full Year 2023 Results
finanznachrichten.de - March 14 at 10:23 AM
iSpecimen Reports Full Year 2023 ResultsiSpecimen Reports Full Year 2023 Results
globenewswire.com - March 14 at 8:00 AM
iSpecimen: Q4 Earnings InsightsiSpecimen: Q4 Earnings Insights
benzinga.com - March 13 at 6:43 PM
Fed rate cuts likely coming after June -strategistFed rate cuts likely coming after June -strategist
nz.finance.yahoo.com - March 13 at 8:42 AM
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference CalliSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
globenewswire.com - March 12 at 7:07 PM
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
globenewswire.com - March 5 at 4:30 PM
iSpecimen Inc: iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchiSpecimen Inc: iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
finanznachrichten.de - January 23 at 9:48 AM
ISpecimen, TriMetis Life Sciences Announce Partnership For Tissue ResearchISpecimen, TriMetis Life Sciences Announce Partnership For Tissue Research
markets.businessinsider.com - January 23 at 9:48 AM
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchiSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
finance.yahoo.com - January 23 at 9:48 AM
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
finance.yahoo.com - January 18 at 8:48 AM
iSpecimen Inc ISPCiSpecimen Inc ISPC
morningstar.com - December 21 at 10:30 PM
iSpecimen Strengthens Global Oncology Biospecimen OfferingiSpecimen Strengthens Global Oncology Biospecimen Offering
finance.yahoo.com - December 7 at 8:30 AM
iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call TranscriptiSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 5 at 2:19 PM
iSpecimen GAAP EPS of -$0.23 beats by $0.12, revenue of $2.78M beats by $0.55MiSpecimen GAAP EPS of -$0.23 beats by $0.12, revenue of $2.78M beats by $0.55M
msn.com - November 2 at 10:20 AM
iSpecimen Reports Third Quarter 2023 Financial and Operating ResultsiSpecimen Reports Third Quarter 2023 Financial and Operating Results
finance.yahoo.com - November 2 at 10:20 AM
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease ResearchiSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
finance.yahoo.com - October 26 at 8:16 AM
iSpecimen expects Q3 revenue above consensusiSpecimen expects Q3 revenue above consensus
msn.com - October 23 at 5:08 PM
Biotech layoffs 2023: In Q3, 19 Boston-area biotechs made cutsBiotech layoffs 2023: In Q3, 19 Boston-area biotechs made cuts
bizjournals.com - October 2 at 10:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bioqual logo

Bioqual

OTCMKTS:BIOQ
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.
Eloxx Pharmaceuticals logo

Eloxx Pharmaceuticals

NASDAQ:ELOX
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
iSpecimen logo

iSpecimen

NASDAQ:ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.